• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[瓦加杜古恶性及准恶性胸腔积液的生存期]

[Survival of malignant and paramalignant pleural effusions in Ouagadougou].

作者信息

Bambara A T, Ouédraogo S M, Maïga S, Sondo K A, Boncoungou/Nikièma K, Ouédraogo G, Koumbem B, Ouédraogo A S, Djibril M, Badoum G, Ouédraogo A R, Ouédraogo M

机构信息

Unité de formation et de recherche en sciences de la santé, BP 7021, Ouagadougou, Burkina Faso; Service de cancérologie, CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso.

Service de médecine interne, CHU Souro Sanou, Bobo-Dioulasso, Burkina Faso; Institut supérieur des sciences de la santé, Bobo-Dioulasso, Burkina Faso.

出版信息

Rev Pneumol Clin. 2016 Dec;72(6):346-352. doi: 10.1016/j.pneumo.2016.08.001. Epub 2016 Oct 21.

DOI:10.1016/j.pneumo.2016.08.001
PMID:27776946
Abstract

This study aimed to present the survival of patients with malignant and paramalignant pleural effusion (MPE) in a context of resource-limited countries. We retrospectively studied patients received for malignant and paramalignant pleural effusion in three health facilities in Ouagadougou from 1st August 2009 to 30 July 2015. Survival was analyzed according to various characteristics related to patients and disease. Eighty patients with a mean age of 54 years were selected. The sex-ratio was 0.9. Sixteen patients had comorbidities. Pleural effusion was revealing, synchronous and metachronous in respectively 55 %, 26.3 % and 17.5 % of cases. Lung cancer was the most common cause of MPE (27.5 %), followed by breast cancer (18.7 %). The median overall survival was 3 months; it varied between primary cancers: 5 months for primary cancer unknown, 4 months for lung cancers and 2 months for breast cancers. Sex and the presence of comorbidities were independent factors influencing survival of patients. In this study, patient survival length is strongly compromised by inadequacies of medical technical equipment.

摘要

本研究旨在介绍资源有限国家恶性及准恶性胸腔积液(MPE)患者的生存情况。我们回顾性研究了2009年8月1日至2015年7月30日期间在瓦加杜古的三个医疗机构收治的恶性及准恶性胸腔积液患者。根据与患者和疾病相关的各种特征分析生存情况。选取了80例平均年龄为54岁的患者。男女比例为0.9。16例患者有合并症。胸腔积液分别在55%、26.3%和17.5%的病例中为首发、同步和异时性。肺癌是MPE最常见的病因(27.5%),其次是乳腺癌(18.7%)。中位总生存期为3个月;在原发性癌症之间有所不同:原发性癌症不明者为5个月,肺癌为4个月,乳腺癌为2个月。性别和合并症的存在是影响患者生存的独立因素。在本研究中,医疗技术设备的不足严重影响了患者的生存时长。

相似文献

1
[Survival of malignant and paramalignant pleural effusions in Ouagadougou].[瓦加杜古恶性及准恶性胸腔积液的生存期]
Rev Pneumol Clin. 2016 Dec;72(6):346-352. doi: 10.1016/j.pneumo.2016.08.001. Epub 2016 Oct 21.
2
Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.通过结合临床、放射学和胸水分析参数预测恶性及准恶性胸腔积液
Lung. 2017 Oct;195(5):653-660. doi: 10.1007/s00408-017-0032-3. Epub 2017 Jun 27.
3
Important prognostic factors for survival in patients with malignant pleural effusion.恶性胸腔积液患者生存的重要预后因素。
BMC Pulm Med. 2015 Mar 28;15:29. doi: 10.1186/s12890-015-0025-z.
4
Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.影响非小细胞肺癌伴恶性胸腔积液患者生存的预后因素。
Clin Respir J. 2016 Nov;10(6):791-799. doi: 10.1111/crj.12292. Epub 2015 Apr 15.
5
Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion.恶性胸腔积液伴发或异时性恶性胸腔积液的预后。
Lung. 2017 Dec;195(6):775-779. doi: 10.1007/s00408-017-0050-1. Epub 2017 Sep 12.
6
Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.恶性胸腔积液中生存素水平的诊断和预后意义。
Respir Med. 2013 Aug;107(8):1260-5. doi: 10.1016/j.rmed.2013.04.011. Epub 2013 Jun 18.
7
Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion.肺癌所致嗜酸性胸腔积液的预后优于非嗜酸性恶性胸腔积液。
Cancer Immunol Immunother. 2022 Feb;71(2):365-372. doi: 10.1007/s00262-021-02994-5. Epub 2021 Jun 25.
8
Prognostic factors in patients with malignant pleural effusion: Is it possible to predict mortality in patients with good performance status?恶性胸腔积液患者的预后因素:对于体能状态良好的患者,是否有可能预测其死亡率?
J Surg Oncol. 2016 Apr;113(5):570-4. doi: 10.1002/jso.24168. Epub 2016 Jan 11.
9
Prognostic significance of pleural fluid data in patients with malignant effusion.恶性胸腔积液患者胸腔积液数据的预后意义
Eur J Intern Med. 2008 Jul;19(5):334-9. doi: 10.1016/j.ejim.2007.09.014. Epub 2007 Nov 8.
10
New approaches in the diagnostic procedure of malignant pleural effusions.恶性胸腔积液诊断程序中的新方法。
Oncol Rep. 2004 Jul;12(1):79-83.